Type 3 hemochromatosis and β-thalassemia trait

European Journal of Haematology

Volumn 72, Issue 5, 2004, Pages 370-374

  Riva, Alessia ^a   Mariani, Raffaella ^a   Bovo, Giorgio ^a   Pelucchi, Sara ^a   Arosio, Cristina ^a   Salvioni, Alessandra ^a   Vergani, Anna ^a,b   Piperno, Alberto ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

thalassemia trait; Hemochromatosis; Iron chelation therapy; TFR2 gene

Indexed keywords

DEFEROXAMINE; DIURETIC AGENT; IRON; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; BETA THALASSEMIA; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER SINUSOID; MACROPHAGE; MALE; PHENOTYPE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AMINO ACID SUBSTITUTION; BETA-THALASSEMIA; BIOPSY; CARDIOMYOPATHY, DILATED; CHELATION THERAPY; DEFEROXAMINE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EXONS; HEMOCHROMATOSIS; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; LIVER CIRRHOSIS; MALE; MUTATION, MISSENSE; RECEPTORS, TRANSFERRIN;

EID: 1942501094     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00230.x     Document Type: Article

References (25)

1. ROETTO A, TOTARO A, PIPERNO A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-2560.
2. GIRELLI D, BOZZINI C, ROETTO A, et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 2002;122:1295-1302.
3. MATTMAN A, HUNTSMAN D, LOCKITCH G, et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood 2002;100:1075-1077.
4. KAWABATA H, YANG R, HIRAMA T, et al. Molecular cloning of transferrin receptor 2. J Biol Chem 1999;274:20826-20832.
5. ISHAK K, BAPTISTA A, BIANCHI L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22: 696-699.
6. DEUGNIER YM, LOREAL O, TURLIN BD, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-2059.
7. OLYNIK J. O'NEILL R, BRITTON R, BACON B. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology 1994;106:674-677.
8. PAPANICOLAU G, SAMUELS ME, LUDWIG EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genet 2004;36: 77-82.
9. CAMASCHELLA C, ROETTO A, DE GOBBI M. Juvenile hemochromatosis. Sem Hematol 2002;39:242-248.
10. DE GOBBI M, ROETTO A, PIPERNO A, MARIANI R, ALBERTI F, PAPANIKOLAOU G, et al. Natural history of juvenile haemochromatosis. Br J Haematol 2002;117:973-979.
11. CECCHETTI G, BINDA A, PIPERNO A, NADOR F, FARGION S, FIORELLI G. Cardiac alterations in 36 consecutive patients with idiopathic hemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 1991;12: 224-230.
12. STROHMEYER G, NIEDERAU C. Diabetes mellitus and hemochromatosis. In: BARTON JC, EDWARDS CQ, eds. Hemochromatosis. Genetics, Pathophysiology, Diagnosis and Treatment. Cambrige. UK: Cambrige University Press, 2000:268-277.
13. WALSH CH. Non diabetic endocrinopathy in hemochromatosis. In: BARTON JC, EDWARDS CQ, eds. Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment. Cambrige, UK: Cambrige University Press, 2000:278-289.
14. FLEMING RE, AHMANN JR, MIGAS MC, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. PNAS 2002;99:10653-10658.
15. DULLMANN J, WULFHEKEL U. The diagnostic significance of bone marrow iron in hereditary hemochromatosis. In: WEINTRAUB LR. EDWARDS CQ, KRIKKER M, eds. Hemochromatosis. Proceedings of the First International Conference. Ann NY Acad Sci 1988;526:357-360.
16. PIPERNO A, MARIANI R, AROSIO C, et al. Haemochromatosis in patients with B-thalassemia trait. Br J Haematol 2000;111:908-914.
17. ROETTO A, PAPANIKOLAOU G, POLITOU M, ALBERTI F, GIRELLI D, CHRISTAKIS J, LOUKOPOULOS D, CAMASCHELLA C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33: 21-22.
18. NICOLAS G, BENNOUN M, DEVAUX I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-8785.
19. ZHOU XY, TOMATSU S, FLEMING RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492-2497.
20. GRIFFITHS WJ, COX TM. Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferring receptor (TFR2) in intestinal tissue and cells. J Histochem Cytochem 2003;51:613-624.
21. DEAGLIO S, CAPOBIANCO A, CALÌ A, et al. Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and polyclonal antiserum. Blood 2002;100:3782-3789.
22. BASTIN JM, JONES M, O'CALLAGHAN CA, SHIMANSKI L, MASON DY, TOWNSEND AR. Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary hemochromatosis. Br J Haematol 1998;103:931-941.
23. ZHANG A-S, XIONG S, TSUKAMOTO H, ENNS CA. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 2004;103:1509-1514.
24. PIPERNO A, ROETTO A, MARIANI R, PELUCCHI S, CORENGIA C, DARAIO F, et al. Homozygosity for transferrin receptor 2 Y250X mutation induces early iron overload. Haematologica 2004, (in press).
25. GEHRKE SG, KULAKSIZ H, HERRMANN T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron. Blood 2003;102:371-376.